Clinical trials
Phase 2 Obesity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Boehringer Ingelheim | 4 |
| Novo Nordisk A/S | 4 |
| Pfizer | 4 |
| AstraZeneca | 3 |
| Novartis Pharmaceuticals | 3 |
| University of Alberta | 3 |
| Golo | 2 |
| Amgen | 1 |
| Canadian Center for Functional Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 46 |
| Overweight | 19 |
| Diabetes Mellitus, Type 2 | 13 |
| Diabetes Mellitus | 4 |
| Weight Loss | 4 |
| Metabolic Syndrome | 3 |
| Inflammation | 2 |
| Insulin Resistance | 2 |
| Nutrition Disorders | 2 |
| Prediabetic State | 2 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.